These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 18808416

  • 1. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF.
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [Abstract] [Full Text] [Related]

  • 2. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F, Grosso F, Terracina M, Ruffelli M, Cordiali-Fei P, Sera F, Zambruno G, Mastrogiacomo A, Di Zenzo G.
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [Abstract] [Full Text] [Related]

  • 3. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J, Jaunin F, Favre B, Büdinger L, Hertl M, Saurat JH, Borradori L.
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y, Ochiai T, Kawamura A, Arakawa H, Fukuda K, Hashimoto T.
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T.
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y, Nishie W, Izumi K, Shimizu H.
    Front Immunol; 2019 Jan; 10():1224. PubMed ID: 31191560
    [Abstract] [Full Text] [Related]

  • 14. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.
    Pomponi D, Di Zenzo G, Zennaro D, Calabresi V, Eming R, Zuzzi S, Bernardi ML, Scala E, Mari A.
    Br J Dermatol; 2013 Jun; 168(6):1205-14. PubMed ID: 23252883
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K.
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [Abstract] [Full Text] [Related]

  • 16. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L, Xiping Z, Li L, Jun P, Yi-Xia W, Min Y, Qing L, Qiu-Ning S, Hong-Zhong J, Ya-Gang Z.
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N, Allen J, Ali I, Venning V, Wojnarowska F.
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.